- Report
- October 2025
- 140 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- October 2025
- 84 Pages
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- October 2025
- 97 Pages
Global
From €4286EUR$4,850USD£3,776GBP
- Report
- October 2025
- 135 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- October 2025
- 140 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- October 2025
- 197 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- October 2025
- 109 Pages
Global
From €3049EUR$3,450USD£2,686GBP
- Report
- September 2025
- 145 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- July 2025
- 132 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- June 2025
- 106 Pages
Global
From €3049EUR$3,450USD£2,686GBP
- Report
- June 2025
- 194 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- June 2025
- 132 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- May 2025
- 133 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- May 2025
- 135 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- April 2025
- 210 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- April 2025
- 225 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- April 2025
- 135 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- March 2025
- 138 Pages
Global
From €3643EUR$4,123USD£3,209GBP
€4286EUR$4,850USD£3,776GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2519EUR$2,850USD£2,219GBP
- Report
- February 2025
- 246 Pages
United States
From €3181EUR$3,599USD£2,802GBP
€4241EUR$4,799USD£3,736GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more